Trospium Chloride Treatment of Overactive Bladder

@article{Biastre2009TrospiumCT,
  title={Trospium Chloride Treatment of Overactive Bladder},
  author={Kelly Biastre and Thomas G. Burnakis},
  journal={Annals of Pharmacotherapy},
  year={2009},
  volume={43},
  pages={283 - 295}
}
Objective: To review the pharmacology, pharmacokinetics, safety, and clinical application of trospium chloride for the management of overactive bladder (OAB). Data Sources: Clinical literature including both primary sources and review articles was accessed through MEDLINE, International Pharmaceutical Abstracts, and Cochrane databases from 1980 through January 8, 2009. Search terms included overactive bladder, urge urinary incontinence, muscarinic receptor antagonists, and urinary frequency… 

Figures and Tables from this paper

Treatments for overactive bladder: focus on pharmacotherapy.
  • R. Geoffrion
  • Medicine
    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
  • 2012
No. 283-Treatments for Overactive Bladder: Focus on Pharmacotherapy.
  • R. Geoffrion
  • Medicine
    Journal of obstetrics and gynaecology Canada : JOGC = Journal d'obstetrique et gynecologie du Canada : JOGC
  • 2018
Effect of Anticholinergic Use for the Treatment of Overactive Bladder on Cognitive Function in Postmenopausal Women
TLDR
Investigation of the effect of an anticholinergic medication, trospium chloride, on cognitive function in post-menopausal women being treated for OAB found cognitive changes occurred weeks prior to OAB symptom improvement, but normalized within 4 weeks.
Effect of trospium chloride therapy on intraocular pressure and tear secretion in overactive bladder patients
TLDR
Trospium chloride can be safely used in female OAB patients with normal IOP and no comorbidity as regards IOP changes as it did not cause a significant change in IOP in these patients.
Effectiveness of Solifenacin and Trospium for Managing of Severe Symptoms of Overactive Bladder in Patients With Benign Prostatic Hyperplasia
TLDR
Combination of trospium and solifenacin in standard doses is an efficient and safe method of management of severe symptoms of OAB in the course of the treatment of with tamsulosin in patients more than 50 years of age.
The Overactive Bladder: New Concepts of Etiology and Treatment
TLDR
Overactive bladder (OAB) is a disorder characterized by urinary urgency and recent evidence has provided a clearer understanding of the neurological, chemical, and functional physiology of the bladder and how it relates to the pathophysiology of OAB.
Effect of Trospium Chloride on Cognitive Function in Women Aged 50 and Older: A Randomized Trial
TLDR
In women aged 50 years and older, there were no changes in cognitive function between those taking trospium and placebo, and cognitive function was correlated with age.
The cost-effectiveness of solifenacin vs. trospium in the treatment of patients with overactive bladder in the German National Health Service
TLDR
Solifenacin would appear to be cost-effective with an ICER of no more than €20,000/QALY, however, small differences in utility between the alternatives means that the results are sensitive to adjustments in the values of the assigned utilities, effectiveness and discontinuation rates.
Oxybutynin and trospium are substrates of the human organic cation transporters
TLDR
High non-specific uptake of [3H]oxybutynin was very high in all transfected HEK293 cells and only a small portion was due to specific, decynium-22-sensitive hOCT-mediated uptake, which is obviously a consequence of the high lipophilicity of this uncharged drug.
Pharmacokinetic and bioequivalence studies of trospium chloride after a single-dose administration in healthy Chinese volunteers.
TLDR
The study aimed to compare and evaluate the bioequivalence of a new generic preparation of trospium chloride capsule and the available import tablet for the requirement of state regulatory criteria in China.
...
...

References

SHOWING 1-10 OF 110 REFERENCES
The challenge of overactive bladder therapy: alternative to antimuscarinic agents.
  • M. Lazzeri, M. Spinelli
  • Medicine, Biology
    International braz j urol : official journal of the Brazilian Society of Urology
  • 2006
TLDR
The pathophysiology of micturition reflex, the current therapies for OAB and the rationale for alternative treatments are reviewed, the potential use of medications targeting the central nervous system (CNS) and the primary sensory nerves of the bladder wall are critically addressed.
Clinical Pharmacokinetics of Trospium Chloride
TLDR
The pharmacokinetics of trospium chloride have been investigated in healthy volunteers, in patients with renal and hepatic impairment, and in those with symptoms of overactive bladder, after oral, intravenous and intravesical administration.
Newer agents for the management of overactive bladder.
TLDR
In general, the newer agents appear to be at least as effective as their predecessors, although it is unclear whether they are better tolerated.
Anticholinergic drugs versus placebo for overactive bladder syndrome in adults.
TLDR
The use of anticholinergic drugs by people with overactive bladder syndrome results in statistically significant improvements in symptoms and modest sized improvements in quality of life scores were reported in recently completed trials.
Effects of Tolterodine, Trospium Chloride, and Oxybutynin on the Central Nervous System
TLDR
The results of this study support the findings that oxybutynin as a tertiary amine crosses the blood‐brain barrier, causing significant qEEG activity changes and more pronounced central adverse effects.
Trospium chloride: an update on a quaternary anticholinergic for treatment of urge urinary incontinence
  • D. Guay
  • Biology
    Therapeutics and clinical risk management
  • 2005
TLDR
Trospium chloride, dosed 20 mg twice daily, is significantly superior to placebo in improving cystometric parameters, reducing urinary frequency, reducing incontinence episodes, and increasing urine volume per micturition.
Maximizing anticholinergic therapy for overactive bladder: has the ceiling been reached?
TLDR
Among approved OAB agents, the oxybutynin transdermal‐delivery system has been associated with a lower incidence of dry mouth than immediate‐ and extended‐release formulations of traditional agents, and is a likely candidate for older patients taking multiple medications.
...
...